<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28099605</article-id>
      <article-id pub-id-type="pmc">5193194</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20165182</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acute localized exanthematous pustulosis caused by cefoperazone and
sodium sulbactam<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Qu</surname>
            <given-names>Yan-Jing</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Shu-Bin</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Xiang-Chun</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>Li-Qiang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff4">4</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> The 251st Hospital of Chinese PLA &#x2013; Zhangjiakou city, China</aff>
      <aff id="aff2"><label>2</label> HanDan Central Hospital - Handan city, China</aff>
      <aff id="aff3"><label>3</label> The First Affiliated Hospital to Hebei North University -
Zhangjiakou city, China</aff>
      <aff id="aff4"><label>4</label> Chinese People's Liberation Army General Hospital - Beijing,
China</aff>
      <author-notes>
        <corresp id="c1"><bold>Mailing address:</bold> Li-Qiang Zheng, Department of
Dermatology, The 251st Hospital of Chinese PLA, No.13, Jian'guo Road,
Zhangjiakou city, Hebei Province, 075000, China, Department of Dermatology,
Chinese People's Liberation Army General Hospital, 28, Fuxing Road, Hai Dian
District, Beijing 100853, China, E-mail:
<email>zlqiang1976@163.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>6</issue>
      <fpage>808</fpage>
      <lpage>810</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Acute localized exanthematous pustulosis is a localized variant of acute
generalized exanthematous pustulosis, which is characterized by the eruption of
multiple scattered pustules following drug administration. A 72-year-old woman
presented with multiple erythematous pustules on her face, which had appeared
two days after using cefoperazone and sodium sulbactam. Histopathological
findings showed subcorneal pustules and mixed inflammatory cell infiltration in
the dermis. The pustules resolved within about two weeks after the patient
discontinued the antibiotics. This report discusses the case of a woman with a
cutaneous drug reaction consistent with acute localized exanthematous pustulosis
that occurred after cefoperazone and sodium sulbactam were administered.</p>
      </abstract>
      <kwd-group>
        <kwd>Acute generalized exanthematous pustulosis</kwd>
        <kwd>Cefoperazone</kwd>
        <kwd>Sulbactam</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Acute generalized exanthematic pustulosis (AGEP) is a rare but well-known cutaneous
reaction pattern, mostly caused by drugs.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> This condition is characterized by a generalized rash and
sterile, disseminated, sometimes coalescing, subcorneal pustules on an erythematous
background. The reaction is self-limited once the causative drug is withdrawn. A
localized variant of AGEP, acute localized exanthematous pustulosis (ALEP), occurs
rarely.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> Previous studies
have found that drugs like amoxicillin, levofloxacin, paracetamol, ibuprofen,
finasteride and piperacillin/tazobactam may induce ALEP attacks.<sup><xref rid="r3" ref-type="bibr">3</xref>-<xref rid="r8" ref-type="bibr">8</xref></sup> Herein, the authors describe a case of ALEP associated with
cefoperazone and sodium sulbactam.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 72-year-old woman was admitted to our hospital due to pneumonia, involving a fever
of 38.0&#xBA;C, a cough and yellow sputum, and nausea without vomiting. She was treated
with cefoperazone and sodium sulbactam for two days (3g, b.i.d, iv gtt). Later, she
had a higher fever of 40&#xBA;C and complained of an acute outbreak of multiple pustular
lesions, affecting her face. Physical examination revealed multiple pustules
underlying erythema, symmetrically involving her cheeks, auricles and oral lips with
erosion and crust (<xref ref-type="fig" rid="f1">Figure 1</xref>). Given the
possible allergic reaction to the drug and the extent of renal dysfunction (Serum
creatinine 251.3umol/L and BUN 13.1mmol/L), over the following seven days,
cefoperazone and sodium sulbactam were discontinued. To prevent secondary infection,
topical treatment with phudicin cream was employed. The acute eruption subsided
gradually and resolved completely within 10 days, followed by punctiform
pigmentation (<xref ref-type="fig" rid="f1">Figure 1</xref>). She had a medical
history of hypertension (20 years' duration), treated with enalapril maleate (10mg,
q.d, p.o); and of cerebral infarction (5 years) without timely treatment. Her blood
pressure was well-controlled while barylalia sequelae persisted. No history of
herpes zoster or psoriasis was recorded.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>(a)-(c) Multiple pustules underlying erythema, distributed symmetrically,
involving her cheeks, auricles and lips with erosion and crust on day
1.(d)-(f) Pustules subsided rapidly on day 4 after the suspicious drug was
withdrawn.(g)-(i) The rash disappeared completely on day 12</p>
          </caption>
          <graphic xlink:href="abd-91-06-0808-g01"/>
        </fig>
      </p>
      <p>A lesional biopsy specimen from the right auricle revealed a slight psoriasiform
acanthosis in association with spongiosis, and infiltration of the epidermis by
neutrophils, resulting in the formation of subcorneal pustules, consistent with AGEP
(<xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Histopathological features revealed subcorneal pustules were accompanied by a
slight psoriasiform acanthosis in association with spongiosis.
(HE:&#xD7;200)</p>
          </caption>
          <graphic xlink:href="abd-91-06-0808-g02"/>
        </fig>
      </p>
      <p>Laboratory data from the 1st, 4th, 7th to 12th days were significant (<xref ref-type="fig" rid="f3">Figure 3</xref>). The results of viral cultures and PCR,
as well as bacterial and fungal cultures of skin lesions, proved negative.</p>
      <p>
        <fig id="f3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Laboratory data from the 1st, 4th, 7th to 12th days were recorded</p>
          </caption>
          <graphic xlink:href="abd-91-06-0808-g03"/>
        </fig>
      </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>AGEP is a severe, usually drug-related, skin eruption characterized by acute
formation of sterile pustules on an erythematous background, entailing an associated
fever and neutrophilia.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> Commonly
associated drugs include macrolide antibiotics, aminopenicillins, quinolones,
hydroxychloroquine, sulfonamides, terbinafine and diltiazem. On average, the onset
of lesions varies from as early as 24 hours after therapy initiation, to 1 to 2
weeks following treatment. <sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r9" ref-type="bibr">9</xref></sup></p>
      <p>Skin symptoms resolve rapidly within a few days without treatment. The rash is
usually accentuated in the large folds. Mucous membrane involvement is rare,
commonly mild, and generally restricted to one site, mostly the oral lips.</p>
      <p>Histology shows: subcorneal pustules, intradermal pustules, or both; sometimes
pronounced edema in the papillary dermis; and perivascular infiltrates consisting of
neutrophils and sometimes eosinophils.<sup><xref rid="r1" ref-type="bibr">1</xref></sup></p>
      <p>The physiopathological mechanisms of AGEP remain uncertain, but drug-specific
positive patch test responses and in vitro lymphocyte proliferative responses in
patients with a history of AGEP strongly suggest that this reaction occurs by a
drug-specific, T-cell-mediated process.<sup><xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup> IL-8 is likely responsible for recruiting
neutrophils in the intraepithelial pustules. Recently, a relative increase in TH17
cell numbers and elevated levels of cytokine IL-22 in the peripheral blood of
patients with AGEP was shown. TH17 cells may increase IL-8 production by
keratinocytes through the effects of IL-17 and IL-22.<sup><xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Some authors suggest the term ALEP for this possible variant of AGEP, because both
the clinical and histopathologic findings of ALEP are similar to those of AGEP. The
definition of ALEP was introduced by Prange <italic>et al.</italic><sup><xref rid="r2" ref-type="bibr">2</xref></sup> Over 15 ALEP cases have subsequently
been reported.<sup><xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r8" ref-type="bibr">8</xref></sup></p>
      <p>The differential diagnosis included varicella zoster virus infection, allergic
contact dermatitis, infectious folliculitis and IgA pemphigus. However, a Tzanck
smear, a PCR of the virus and bacterial cultures were negative. Notably, the lesions
disappeared immediately after withdrawal of cefoperazone and sodium sulbactam. The
team assumed that this was attributable to the antibiotic.</p>
      <p>In this case, the patient exhibited a symmetrical, localized, pustular eruption on
the face. Simultaneously, she experienced a transient fever, elevated white blood
cells count with neutrophilia, thrombocytopenia, as well as hemostasis and
hypokalemia disorders, and renal dysfunction. As soon as the drug was stopped, the
rash showed a rapid resolution and accordingly, laboratory exams were within normal
values. Recently, a similar case with lesion onn the upper thigh was reported
following piperacillin/tazobactam use.<sup><xref rid="r8" ref-type="bibr">8</xref></sup></p>
      <p>As is widely known, the systemic adverse effects of cefoperazone and sodium sulbactam
include gastrointestinal reactions (mild diarrhea, nausea and vomiting, etc.). The
hematological system side effects consist of decreased neutrophils, hemoglobin, and
platelets, hypoprothrombinemia and eosinophilia. Laboratory tests indicated
transient increased AST(SGOT)/ALT(SGPT), alkaline phosphatase, BUN and creatinine
and other side-effects, along with headaches, fever and chills. So far, ALEP
associated with cefoperazone and sodium sulbactam has not been reported.</p>
      <p>Indeed, given the temporal relationship between the administration of the antibiotic
and the development of the skin disease and the histologic findings, the authors
consider this to be an unusual type of AGEP, defined as ALEP induced by cefoperazone
and sodium sulbactam.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at the Department of Dermatology, The 251st Hospital of Chinese
PLA &#x2013; Zhangjiakou city, China.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roujeau</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Bioulac-Sage</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bourseau</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis Analysis of 63
cases</article-title>
          <source>Arch Dermatol</source>
          <year>1991</year>
          <volume>127</volume>
          <fpage>1333</fpage>
          <lpage>1338</lpage>
          <pub-id pub-id-type="pmid">1832534</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prange</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Marini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kalke</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute localized exanthematous pustulosis (ALEP)</article-title>
          <source>J Dtsch Dermatol Ges</source>
          <year>2005</year>
          <volume>3</volume>
          <fpage>210</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="pmid">16372816</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Betto</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Germi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bonoldi</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute localized exanthematous pustulosis (ALEP) caused by
amoxicillin-clavulanic acid</article-title>
          <source>Int J Dermatol</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>295</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">18289337</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corral de la Calle</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martin Diaz</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Flores</surname>
              <given-names>CR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute localized exanthematous pustulosis secondary to
levofloxacin</article-title>
          <source>Br J Dermatol</source>
          <year>2005</year>
          <volume>152</volume>
          <fpage>1076</fpage>
          <lpage>1077</lpage>
          <pub-id pub-id-type="pmid">15888181</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rastogi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Modi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dhawan</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Acute localized exanthematous pustulosis (ALEP) caused by
ibuprofen. A case report</article-title>
          <source>Br J Oral Maxillofac Surg</source>
          <year>2009</year>
          <volume>47</volume>
          <fpage>132</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="pmid">18783858</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>UH</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>SJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute localized exanthematous pustulosis induced by
docetaxel</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2010</year>
          <volume>63</volume>
          <fpage>e44</fpage>
          <lpage>e46</lpage>
          <pub-id pub-id-type="pmid">20633784</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tresch</surname>
              <given-names>Sandra</given-names>
            </name>
            <name>
              <surname>Cozzio</surname>
              <given-names>Antonio</given-names>
            </name>
            <name>
              <surname>Cozzio</surname>
              <given-names>Antonio</given-names>
            </name>
            <name>
              <surname>Kamarashev</surname>
              <given-names>Jivko</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>T cell-mediated acute localized exanthematous pustulosis caused
by finasteride</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2012</year>
          <volume>129</volume>
          <fpage>589</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="pmid">21868079</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huilaja</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kallioinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Soronen</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Acute Localized Exanthematous Pustulosis on Inguinal Area
Secondary to Piperacillin/tazobactam</article-title>
          <source>Acta Derm Venereol</source>
          <year>2014</year>
          <volume>94</volume>
          <fpage>106</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">23817479</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sidoroff</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dunant</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Viboud</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk factors for acute generalized exanthematous pustulosis
(AGEP) results of a multinational case-control study
(EuroSCAR)</article-title>
          <source>Br J Dermatol</source>
          <year>2007</year>
          <volume>157</volume>
          <fpage>989</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="pmid">17854366</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kabashima</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sugita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sawada</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased circulating Th17 frequencies and serum IL-22 levels in
patients with acute generalized exanthematous pustulosis</article-title>
          <source>J Eur Acad Dermatol Venereol</source>
          <year>2011</year>
          <volume>25</volume>
          <fpage>485</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="pmid">20569282</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
